Version 5.4
Homo sapiens Protein: COL3A1
Summary
InnateDB Protein IDBP-77199.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol COL3A1
Protein Name collagen, type III, alpha 1
Synonyms EDS4A;
Species Homo sapiens
Ensembl Protein ENSP00000315243
InnateDB Gene IDBG-77195 (COL3A1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 14 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Experimentally validated
Total 14 [view]
Protein-Protein 13 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005201 extracellular matrix structural constituent
GO:0005515 protein binding
Biological Process
Cellular Component
GO:0005581 collagen trimer
Protein Structure and Domains
PDB ID
InterPro IPR000885 Fibrillar collagen, C-terminal
IPR001007 von Willebrand factor, type C
IPR002181 Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain
IPR008160 Collagen triple helix repeat
PFAM PF01410
PF00093
PF00147
PF01391
PRINTS
PIRSF
SMART SM00038
SM00214
SM00186
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL V9GZM1
UniProt Splice Variant
Entrez Gene 1281
UniGene Hs.708235
RefSeq
HUGO HGNC:2201
OMIM 120180
CCDS
HPRD 00365
IMGT
EMBL M10796 M10797 M10798 X01742
GenPept AAA51998 AAA51999 AAA52000 CAA25878

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca